Tumor suppressor loci on mouse chromosomes 9 and 16 are lost at distinct stages of tumorigenesis in a transgenic model of islet cell carcinoma.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Cancer Research

• Publication date

  1995-12-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8521395
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vascular endothelial growth factor and its receptors, flt-1 and flk-1, are expressed in normal pancreatic islets and throughout islet cell tumorigenesis.

  1995cited by this paper
• Molecular dissection of multi-stage tumorigenesis in transgenic mice.

  1994cited by this paper
• Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells

  1994cited by this paper
• Allelotype analysis of mouse lung carcinomas reveals frequent allelic losses on chromosome 4 and an association between allelic imbalances on chromosome 6 and K-ras activation.

  1994cited by this paper
• A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis

  1994influential reference
• Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1.

  1994cited by this paper
• Genome-wide search for loss of heterozygosity in transgenic mouse tumors reveals candidate tumor suppressor genes on chromosomes 9 and 16.

  1994influential reference
• A genetic map of the mouse with 4,006 simple sequence length polymorphisms

  1994cited by this paper
• Insulin-like growth factor II is focally up-regulated and functionally involved as a second signal for oncogene-induced tumorigenesis.

  1994influential reference
• Angiogenic macrophages produce the angiogenic inhibitor thrombospondin 1.

  1993cited by this paper
• Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity

  1993cited by this paper
• The multistep nature of cancer.

  1993cited by this paper
• Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

  1992cited by this paper
• A genetic map of the mouse suitable for typing intraspecific crosses.

  1992cited by this paper
• A linkage map of mouse chromosome 19: definition of comparative mapping relationships with human chromosomes 10 and 11 including the MEN1 locus.

  1992cited by this paper
• Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors.

  1992cited by this paper
• Accumulation of genetic defects during astrocytoma progression

  1992cited by this paper
• A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin.

  1990cited by this paper
• Complete physical map of the WAGR region of 11p13 localizes a candidate Wilms' tumor gene.

  1990cited by this paper
• Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping

  1990cited by this paper
• Transgenic mice as probes into complex systems.

  1989cited by this paper
• Induction of angiogenesis during the transition from hyperplasia to neoplasia

  1989cited by this paper
• Dissecting multistep tumorigenesis in transgenic mice.

  1988cited by this paper
• Molecular detection of deletions involving band q14 of chromosome 13 in retinoblastomas.

  1986cited by this paper
• Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes.

  1985cited by this paper

• CD93 blockade promotes effector T-cell infiltration and facilitates adoptive cell therapy in solid tumors

  2025cites this paper
• RABL6A Promotes Pancreatic Neuroendocrine Tumor Angiogenesis and Progression In Vivo

  2021cites this paper
• Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic Targets

  2021cites this paper
• Heparanase and the hallmarks of cancer

  2020cites this paper
• Translational research in neuroendocrine tumors: pitfalls and opportunities

  2017cites this paper
• Combined deletion of cathepsin protease family members reveals compensatory mechanisms in cancer

  2016cites this paper
• 24-Hydroxycholesterol participates in pancreatic neuroendocrine tumor development

  2016cites this paper
• Sexual dimorphism of liver metastasis by murine pancreatic neuroendocrine tumors is affected by expression of complement C5

  2016cites this paper
• Chemical Conjugate of Low Molecular Weight Heparin and Suramin Fragment Inhibits Tumor Growth Possibly by Blocking VEGF165.

  2015cites this paper
• A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics.

  2015cites this paper
• SV40 TAg mouse models of cancer.

  2014cites this paper
• Determinants for in vivo antitumor effect of angiogenesis inhibitor SU5416 formulated in PEGylated emulsion.

  2014cites this paper
• Specific binding of modified ZD6474 (Vandetanib) monomer and its dimer with VEGF receptor-2.

  2013cites this paper
• Relevance of angiogenesis in neuroendocrine tumors

  2012cites this paper
• Estudio de inmunomodulación xenogénica y sus posibles apllcaciones biomédicas

  2012cites this paper
• Acute hypoxia induces apoptosis of pancreatic β-cell by activation of the unfolded protein response and upregulation of CHOP

  2012cites this paper
• Hypoxia inducible factor-1α is necessary for invasive phenotype in Vegf-deleted islet cell tumors

  2012cites this paper
• Counterbalancing angiogenic regulatory factors control the rate of cancer progression and survival in a stage-specific manner

  2011cites this paper
• Loss of p19Arf Facilitates the Angiogenic Switch and Tumor Initiation in a Multi-Stage Cancer Model via p53-Dependent and Independent Mechanisms

  2010cites this paper
• Genetic Deletion of the Desmosomal Component Desmoplakin Promotes Tumor Microinvasion in a Mouse Model of Pancreatic Neuroendocrine Carcinogenesis

  2010cites this paper
• MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer.

  2009cites this paper
• Genetic Ablation of Bcl-x Attenuates Invasiveness without Affecting Apoptosis or Tumor Growth in a Mouse Model of Pancreatic Neuroendocrine Cancer

  2009cites this paper
• Polyproline‐type helical‐structured low‐molecular weight heparin (LMWH)‐taurocholate conjugate as a new angiogenesis inhibitor

  2009cites this paper
• IN VIVO ANALYSIS OF THE ROLE OF TENASCIN-C IN TUMORIGENESIS

  2008cites this paper
• In vivo analysis of the role of tenascin-C in tumorigenesis

  2008cites this paper
• New drug development in digestive neuroendocrine tumors.

  2007cites this paper
• Minimal active domain and mechanism of action of the angiogenesis inhibitor histidine-rich glycoprotein.

  2006cites this paper
• 50 years of preclinical anticancer drug screening: empirical to target-driven approaches.

  2005cites this paper
• Identification of Fetuin-B as a member of a cystatin-like gene family on mouse chromosome 16 with tumor suppressor activity.

  2004cites this paper
• Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis.

  2004cites this paper
• Transfer of Advances in Sciences into Dental Education Angiogenesis in Oral Cancer

  2004cites this paper
• Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors.

  2003cites this paper
• I ntrabody‐based strategies for inhibition of vascular endothelial growth factor receptor‐2: effects on apoptosis, cell growth, and angiogenesis

  2003cites this paper
• Allele-specific Hras mutations and genetic alterations at tumor susceptibility loci in skin carcinomas from interspecific hybrid mice.

  2003cites this paper
• Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis.

  2003cites this paper
• Cancer modeling in the modern era: progress and challenges.

  2002cites this paper
• High frequency loss of heterozygosity in von Hippel-Lindau (VHL)-associated and sporadic pancreatic islet cell tumors: evidence for a stepwise mechanism for malignant conversion in VHL tumorigenesis.

  2002cites this paper
• Putative tumor-suppressor gene regions responsible for radiation lymphomagenesis in F1 mice with different p53 status.

  2002cites this paper
• Genome-wide detection of chromosomal imbalances in tumors using BAC microarrays

  2002cites this paper
• Expression of exogenous protein in the egg white of transgenic chickens

  2002cites this paper
• Frequent deletion of chromosome 3 in malignant sporadic pancreatic endocrine tumors.

  2002cites this paper
• Advances in Brief High Frequency Loss of Heterozygosity in von Hippel-Lindau ( VHL )-associated and Sporadic Pancreatic Islet Cell Tumors : Evidence for a Stepwise Mechanism for Malignant Conversion in VHL Tumorigenesis 1

  2002cites this paper
• Transformation of the microvascular system during multistage tumorigenesis

  2002cites this paper
• Mutational analysis of Smad3, a candidate tumor suppressor implicated in TGF-beta and menin pathways, in parathyroid adenomas and enteropancreatic endocrine tumors.

  2002cites this paper
• VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis.

  2002cites this paper
• Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas

  2001cites this paper
• Multiple allelic deletions and intratumoral genetic heterogeneity in men1 pancreatic tumors.

  2001cites this paper
• Oncogenes, Anti-Oncogenes, and Genetic Regulators of Vascular Development

  2001cites this paper
• Angiogenesis in oral cancer.

  2001cites this paper
• Genetic Studies of Endocrine Abdominal Tumors

  2001influential citation
• Deletion at 3p25.3–p23 is frequently encountered in endocrine pancreatic tumours and is associated with metastatic progression

  2001cites this paper
• The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and function.

  2000cites this paper
• Allele‐specific loss or imbalance of chromosomes 9, 15, and 16 in B‐cell tumors from interspecific F1 hybrid mice carrying eμ‐c‐myc or N‐myc transgenes

  2000cites this paper
• Openings between defective endothelial cells explain tumor vessel leakiness.

  2000cites this paper
• [Effects of endocrine peptides on proliferation, migration and differentiation of human endothelial cells].

  2000cites this paper
• Allelotype analysis of chemically induced squamous cell carcinomas in F(1) hybrids of two inbred mouse strains with different susceptibility to tumor progression.

  2000cites this paper
• Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

  2000cites this paper
• Molecular Mechanisms of Tumor Angiogenesis and Tumor Progression

  2000cites this paper
• Matrix metalloproteinase-9 triggers the angiogenic switch during

  2000cites this paper
• RAD51 as a candidate parathyroid tumour suppressor gene on chromosome 15q: absence of somatic mutations

  1999cites this paper
• Insights into cancer from transgenic mouse models

  1999cites this paper
• Angiogenesis in the development of head and neck cancer and its inhibition by chemopreventive agents.

  1999cites this paper
• SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types.

  1999cites this paper
• Frequent loss of heterozygosity at chromosome 3p14.2–3p21 in human pancreatic islet cell tumours

  1999cites this paper
• Effects of angiogenesis inhibitors on multistage carcinogenesis in mice.

  1999cites this paper
• The 5' flanking region of the human granzyme H gene directs expression to T/natural killer cell progenitors and lymphokine-activated killer cells in transgenic mice.

  1999cites this paper
• [Angiogenesis and endocrine tumors].

  1999cites this paper
• The 5′ Flanking Region of the Human Granzyme H Gene Directs Expression to T/Natural Killer Cell Progenitors and Lymphokine-Activated Killer Cells in Transgenic Mice

  1999cites this paper
• Tumor Cells Utilize Multiple Pathways to Down‐modulate Apoptosis: Lessons from a Mouse Model of Islet Cell Carcinogenesis

  1999cites this paper
• of Multiple Tumor Types Tyrosine Kinase Catalysis , Tumor Vascularization , and Growth Endothelial Growth Factor Receptor ( Flk-1 / KDR ) That Inhibits SU 5416 Is a Potent and Selective Inhibitor of the Vascular

  1998cites this paper
• Localization of putative tumor suppressor loci by genome-wide allelotyping in human pancreatic endocrine tumors.

  1998cites this paper
• Cloning and chromosomal mapping of the human p53-related KET gene to Chromosome 3q27 and its murine homolog Ket to mouse Chromosome 16

  1998influential citation
• Functional analysis of VEGF-B and VEGF-C

  1997cites this paper
• Molekularbiologie solider Tumoren: Eine Zusammenfassung wichtiger Forschungsergebnisse der letzten Jahre

  1997cites this paper
• DNA copy number changes associated with characteristic LOH in islet cell carcinomas of transgenic mice

  1997cites this paper
• Loss of heterozygosity analysis in primary mammary tumors and lung metastases of MMTV-MTAg and MMTV-neu transgenic mice.

  1997cites this paper
• Mouse mammary tumor virus/v-Ha-ras transgene-induced mammary tumors exhibit strain-specific allelic loss on mouse chromosome 4.

  1997cites this paper
• The role of the laboratory mouse in the human genome project.

  1996cites this paper
• Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models.

  1996cites this paper
• Reciprocal paracrine interactions between tumour cells and endothelial cells: the 'angiogenesis progression' hypothesis.

  1996cites this paper
• The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors.

  1996cites this paper
• Dlgh1, a mouse homolog of the drosophila discs-large gene, is located on Chromosome 16

  1996cites this paper
• Counterbalancing Angiogenic Regulatory Factors Control the Rate of Cancer Progression and Survival in a Stage- Specific Manner Accessed Terms of Use Detailed Terms

  year unknowncites this paper